The evaluation of gold-based compounds as potential inhibitors of HIV-1 replication.
Year: 2012
Type: dissertation
Abstract: Highly active antiretroviral therapy has successfully limited HIV-1 disease \nprogression to AIDS, but is consistently compromised by the emergence and \ntransmission of HIV-1 drug resistant strains. As a result, a continued search for novel \nanti-HIV-1 agents with improved pharmacological profiles has become fundamental. \nChrysotherapy has been in use since the early 1920s in treatment of rheumatoid \narthritis, and has since been investigated for various ailments including HIV/AIDS. \nThis study evaluated 45 synthetic gold compounds for drug like properties using \ntheoretical and experimental techniques with the aim of generating sufficient data to \nconsiderably aid the rational design of new anti-HIV agents. Theoretical techniques \napplied included the Osiris Property Explorer and the Lipinski’s Rule of Five which \nassessed drug-likeness and bioavailability respectively. In vitro studies included \naqueous solubility assays, cytotoxicity (PM1 cell lines and PBMCs) assays, antiviral \nassays in PBMCs, direct enzyme (RT and IN) inhibition, and the effect of serum \nprotein binding and biological stability on antiviral efficacy. An overall low druglikeness \nscore and an intermediate bioavailability were predicted by the Osiris \nMolecular Property Explorer. Low drug-likeness was suggested to be due to a high \nfrequency of foreign fragments in the synthetic gold compounds, while their high \nmolecular weight reduced bioavailability. In general gold compounds exhibited \ncytotoxicity properties and moderate aqueous solubility in vitro. Overall, the 45 \nsynthetic gold compounds did not show activity against HIV-1 replication in vitro. \nSeven compounds (AB05-AB11) exhibited direct HIV-1 RT inhibition, and \ncompounds AB39 and AB04 demonstrated moderate direct HIV-1 IN inhibition, but \nthis activity was abrogated in PBMC inhibition assays. Serum binding, compound \nstability and cytotoxicity were all implicated in the lack of HIV-1 inhibition in \nPBMCs. To this end, data obtained was sufficient to aid in the future rational design \nof second generation HIV RT and IN inhibitors with acceptable pharmacological \nproperties.
Author: Morore Katlego Mphahlele
Institution: University of the Witwatersrand
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funder: Mintek
OpenAlex ID: W2252459002
